tumor-multi-omics-form-nolabel

Advancing cancer research and
precision medicine

Dr. Aditi Hazra from Brigham and Women’s Hospital and Harvard Medical School presents a multi-omic approach to inflammatory breast cancer (IBC) biomarker discovery.

See why Dr. Hazra believes that combining somatic mutation, copy number variation (CNV), and gene expression data will increase the probability of identifying biomarkers, especially when compared to evaluating DNA alone.

*
*
*
*
*
*
 Yes, I'd like to receive communication about Life Technologies goods and services via telephone, email, or other electronic means.
 본 개인정보를 Life Technologies 그룹에 제공하는 것에 대해 동의하십니까?*
 Life Technologies 그룹에서 발송하는 이메일 수신에 동의 하십니까?

이 사이트는 reCAPTCHA에 의해 보호되며 Google 개인정보 처리방침 및 서비스 약관이 적용됩니다.

 
 

Understand whole-transcriptome
(WT) profiling

Learn more ›

Obtain genome-wide copy number (CN)
in 48 hours

Learn more ›

Easily integrate CN and WT data 

Learn more ›